PL343004A1 - Use of retinoic acid activity inhibitors to slow down hair loss - Google Patents
Use of retinoic acid activity inhibitors to slow down hair lossInfo
- Publication number
- PL343004A1 PL343004A1 PL99343004A PL34300499A PL343004A1 PL 343004 A1 PL343004 A1 PL 343004A1 PL 99343004 A PL99343004 A PL 99343004A PL 34300499 A PL34300499 A PL 34300499A PL 343004 A1 PL343004 A1 PL 343004A1
- Authority
- PL
- Poland
- Prior art keywords
- slow down
- retinoic acid
- hair loss
- acid activity
- activity inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A61Q7/02—Preparations for inhibiting or slowing hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/603—Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9803978A FR2776511B1 (fr) | 1998-03-31 | 1998-03-31 | Utilisation dans ou pour la preparation d'une composition d'au moins un inhibiteur de l'activite de l'acide retinoique |
Publications (1)
Publication Number | Publication Date |
---|---|
PL343004A1 true PL343004A1 (en) | 2001-07-30 |
Family
ID=9524693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL99343004A PL343004A1 (en) | 1998-03-31 | 1999-03-24 | Use of retinoic acid activity inhibitors to slow down hair loss |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1066017A1 (xx) |
JP (1) | JP2002509870A (xx) |
KR (1) | KR20010042104A (xx) |
CN (1) | CN1298290A (xx) |
AR (1) | AR015551A1 (xx) |
AU (1) | AU2938899A (xx) |
BR (1) | BR9908411A (xx) |
CA (1) | CA2324899A1 (xx) |
FR (1) | FR2776511B1 (xx) |
HU (1) | HUP0102411A3 (xx) |
IL (1) | IL137859A0 (xx) |
NO (1) | NO20004880L (xx) |
PL (1) | PL343004A1 (xx) |
RU (1) | RU2193877C2 (xx) |
WO (1) | WO1999049838A1 (xx) |
ZA (1) | ZA200004483B (xx) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2733684B1 (fr) * | 1995-05-03 | 1997-05-30 | Cird Galderma | Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique |
FR2739777B1 (fr) * | 1995-10-11 | 1997-11-14 | Cird Galderma | Ligand antagoniste rar-gamma ou agoniste rar-alpha en tant qu'inhibiteur d'apoptose |
US5965606A (en) * | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
HUP9902645A3 (en) * | 1996-03-18 | 1999-12-28 | Eisai Co Ltd | Fused-ring carboxylic acid derivatives |
-
1998
- 1998-03-31 FR FR9803978A patent/FR2776511B1/fr not_active Expired - Fee Related
-
1999
- 1999-03-24 KR KR1020007010470A patent/KR20010042104A/ko not_active Application Discontinuation
- 1999-03-24 IL IL13785999A patent/IL137859A0/xx unknown
- 1999-03-24 BR BR9908411-2A patent/BR9908411A/pt not_active IP Right Cessation
- 1999-03-24 RU RU2000127111/14A patent/RU2193877C2/ru active
- 1999-03-24 PL PL99343004A patent/PL343004A1/xx not_active Application Discontinuation
- 1999-03-24 JP JP2000540805A patent/JP2002509870A/ja active Pending
- 1999-03-24 WO PCT/FR1999/000687 patent/WO1999049838A1/fr not_active Application Discontinuation
- 1999-03-24 HU HU0102411A patent/HUP0102411A3/hu unknown
- 1999-03-24 CN CN99804411A patent/CN1298290A/zh active Pending
- 1999-03-24 EP EP99910423A patent/EP1066017A1/fr not_active Withdrawn
- 1999-03-24 CA CA002324899A patent/CA2324899A1/fr not_active Abandoned
- 1999-03-24 AU AU29388/99A patent/AU2938899A/en not_active Abandoned
- 1999-03-30 AR ARP990101412A patent/AR015551A1/es unknown
-
2000
- 2000-08-29 ZA ZA200004483A patent/ZA200004483B/en unknown
- 2000-09-28 NO NO20004880A patent/NO20004880L/no unknown
Also Published As
Publication number | Publication date |
---|---|
WO1999049838A1 (fr) | 1999-10-07 |
CN1298290A (zh) | 2001-06-06 |
HUP0102411A3 (en) | 2002-12-28 |
FR2776511B1 (fr) | 2001-05-11 |
AU2938899A (en) | 1999-10-18 |
ZA200004483B (en) | 2002-02-27 |
EP1066017A1 (fr) | 2001-01-10 |
HUP0102411A2 (hu) | 2001-11-28 |
NO20004880D0 (no) | 2000-09-28 |
NO20004880L (no) | 2000-11-30 |
CA2324899A1 (fr) | 1999-10-07 |
FR2776511A1 (fr) | 1999-10-01 |
JP2002509870A (ja) | 2002-04-02 |
BR9908411A (pt) | 2000-12-05 |
IL137859A0 (en) | 2001-10-31 |
AR015551A1 (es) | 2001-05-02 |
RU2193877C2 (ru) | 2002-12-10 |
KR20010042104A (ko) | 2001-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL328871A1 (en) | Substituted derivatives of 4-hydroxyphenyloalcanic acid exhibiting antagonistic activity in respect to ppar-gamma | |
PL341059A1 (en) | Mimetic anilides of retinoic acid | |
IL134851A0 (en) | Prostaglandin agonists and their use to treat bone disorders | |
AU2592699A (en) | Introduction of nucleic acid into skin cells by topical application | |
PL338633A1 (en) | Derivatives of aryloxyarylsuphonylamino hydroxamic acid | |
PL335027A1 (en) | Derivatives of arylsulphonylamino hydroxamic acid | |
PL341379A1 (en) | Aromatic sulphone substituted hydroxamic acid as inhibitor of metalloprotease | |
DE69822669D1 (de) | Verminderung des haarwuchses | |
AU2001290936A1 (en) | Application of water nanoclusters to skin | |
DE69934510D1 (de) | Verminderung des haarwuchses | |
AU2001278006A1 (en) | Agonists of follicle stimulating hormone activity | |
DE69813935D1 (de) | Verwendung von Retinoiden zur Induzierung von Hautpigmentierung | |
DE69825607D1 (de) | Verminderung des haarwuchses | |
PL332430A1 (en) | Skin care compositions containing combinations of compounds capable to simulate the action of retinic acid onto skin | |
AU4306197A (en) | Use of inhibitors of the activity of retinoic acid to promote healing | |
GB9807464D0 (en) | Purification of human acid µ-glucosidase | |
AU5087999A (en) | Acid/irritant neutralization of skin | |
PL351986A1 (en) | Method of reducing il-5 activity | |
EP1007036A4 (en) | METHODS OF USING BUTYRIC ACID OR BUTYRIC ACID DERIVATIVES TO PREVENT HAIR LOSS | |
PL356092A1 (en) | Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use | |
EP1109582A4 (en) | METHOD FOR STRENGTHENING AND RESTRICTING GENE EXPRESSION | |
ZA879063B (en) | Use of 13-cis retinoic acid | |
IL137859A0 (en) | Use of retinoic acid activity inhibitors to slow down hair loss | |
AU8398398A (en) | Modification of nitric oxide activity to treat fas-induced pathologies | |
GB9726965D0 (en) | Transfer of basic knowledge to agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |